{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:36:02Z","timestamp":1791974162098,"version":"4.4.0"},"reference-count":204,"publisher":"Walter de Gruyter GmbH","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Intraperitoneal chemotherapy has demonstrated significant pharmacologic and clinical advantage over traditional intravenous administration for cancers that are restricted to the peritoneal cavity. The combination of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) has become the standard technique used to fight ovarian and gastrointestinal cancers in many centers. However, challenges remain for HIPEC to contact the entire peritoneal surface, penetrate the tumor tissue, and transport to the lymphatics and other metastatic sites. New innovations in delivery technique, such as heated aerosol, and in delivery molecules, such as microparticles, nanoparticles, nanogels, and tumor-penetrating peptides are being tested in animal models and will likely soon be in human trials. Improvements in overall care, such as the recent clinical trial of an oral agent for maintenance therapy in ovarian carcinoma, will continue in this field for the next 20 years.<\/jats:p>","DOI":"10.1515\/pp-2016-0022","type":"journal-article","created":{"date-parts":[[2016,12,18]],"date-time":"2016-12-18T10:02:20Z","timestamp":1482055340000},"page":"183-191","source":"Crossref","is-referenced-by-count":18,"title":["Pharmacokinetic problems in peritoneal drug administration: an update after 20 years"],"prefix":"10.1515","volume":"1","author":[{"given":"Michael F.","family":"Flessner","sequence":"first","affiliation":[{"name":"1Uniform Services University of Health Sciences, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","reference":[{"key":"ref881","doi-asserted-by":"crossref","first-page":"16157","DOI":"10.1073\/pnas.0908201106","article-title":"C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration","volume":"106","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref1081","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s00432-009-0667-4","article-title":"Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results","volume":"135","year":"2009","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref681","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1245\/s10434-013-3213-1","article-title":"Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressurized aerosol as an alternative to liquid solution: first evidence for efficacy","volume":"21","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"ref1611","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00464-011-1964-y","article-title":"Therapeutic approach of human peritoneal carcinomatosis with Dbait in combination with capnoperitoneum: proof of concept","volume":"26","year":"2012","journal-title":"Surg Endosc"},{"key":"ref181","first-page":"5475","article-title":"Measurement of local Mr 97,000 and 250,000 protein antigen concentration in sections of human melanoma tumor using in vitro quantitative autoradiography","volume":"48","year":"1988","journal-title":"Cancer Res"},{"key":"ref1321","first-page":"253","article-title":"Hyperthermic peritoneal perfusion system in canines","volume":"40","year":"1980","journal-title":"Cancer Res"},{"key":"ref1681","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1007\/s00464-015-4738-0","article-title":"Feasibility of hyperthermic pressurized intraperitoneal aerosol chemotherapy in a porcine model","volume":"30","year":"2016","journal-title":"Surg Endosc"},{"key":"ref1891","first-page":"216","article-title":"Tumor-penetrating peptides","volume":"3","year":"2013;","journal-title":"Front Oncol"},{"key":"ref361","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1053\/ctrv.2001.0232","article-title":"Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy","volume":"27","year":"2001","journal-title":"Cancer Treat Rev"},{"key":"ref701","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1245\/s10434-015-4954-9","article-title":"Exploring the spatial drug distribution pattern of pressurized intraperitoneal aerosol chemotherapy (PIPAC","volume":"23","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"ref1001","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-0-387-68969-2_14","article-title":"Syngeneic mouse model of epithelial ovarian cancer: effects of nanoparticulate paclitaxel, Nanotax","volume":"622","year":"2008;","journal-title":"Adv Exp Med Biol"},{"key":"ref1541","first-page":"6371","article-title":"Interstitial hypertension in human breast and colorectal tumors","volume":"52","year":"1992","journal-title":"Cancer Res"},{"key":"ref1311","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4103\/0972-9941.158965","article-title":"Laparoscopic HIPEC: a bridge between open and closed-techniques","volume":"12","year":"2016","journal-title":"J Minim Access Surg"},{"key":"ref951","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ygyno.2011.04.008","article-title":"HIPEC in recurrent ovarian cancer patients: morbidity-related treatment and long-term analysis of clinical outcome","volume":"122","year":"2011","journal-title":"Gynecol Oncol"},{"key":"ref481","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1158\/1078-0432.CCR-05-2141","article-title":"Intraperitoneal immunotherapy for metastatic ovarian carcinoma: resistance of intratumoral collagen to antibody penetration","volume":"12","year":"2006","journal-title":"Clin Cancer Res"},{"key":"ref1401","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1046\/j.1365-2168.2001.01701.x","article-title":"Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei","volume":"88","year":"2001","journal-title":"Br J Surg"},{"key":"ref761","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0169-409X(97)00048-3","article-title":"Biodegradation and biocompatibility of PLA and PLGA microspheres","volume":"28","year":"1997","journal-title":"Adv Drug Deliv Rev"},{"key":"ref731","first-page":"H26","article-title":"Peritoneal absorption of macromolecules studied by quantitative autoradiography","volume":"248","year":"1985","journal-title":"Am J Physiol"},{"key":"ref991","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00280-015-2737-4","article-title":"A phase I study of intraperitoneal nanoparticulate paclitaxel (Nanotax(R)) in patients with peritoneal malignancies","volume":"75","year":"2015","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref1941","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.biomaterials.2016.07.023","article-title":"iRGD peptide conjugation potentiates intraperitoneal tumor delivery of paclitaxel with polymersomes","volume":"104","year":"2016","journal-title":"Biomaterials"},{"key":"ref601","first-page":"6723","article-title":"Pressurized intraperitoneal aerosol chemotherapy with cisplatin and doxorubicin in women with peritoneal carcinomatosis: a cohort study","volume":"35","year":"2015","journal-title":"Anticancer Res"},{"key":"ref511","first-page":"4478","article-title":"Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy","volume":"150","year":"1990","journal-title":"Cancer Res"},{"key":"ref1601","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s00464-012-2148-0","article-title":"Description of a novel approach for intraperitoneal drug delivery and the related device","volume":"26","year":"2012","journal-title":"Surg Endosc"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/jnci\/89.7.480","article-title":"Pharmacokinetic problems in peritoneal drug administration: tissue penetration and surface exposure","volume":"89","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"ref341","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/bjc.1995.334","article-title":"Hyperthermia, thermotolerance and topoisomerase II inhibitors","volume":"72","year":"1995","journal-title":"Br J Cancer"},{"key":"ref1591","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s004649900010","article-title":"Feasibility of therapeutic pneumoperitoneum in a large animal model using a microvaporisator","volume":"14","year":"2000","journal-title":"Surg Endosc"},{"key":"ref1441","first-page":"F413","article-title":"A distributed model of peritoneal-plasma transport: analysis of experimental data in the rat","volume":"248","year":"1985","journal-title":"Am J Physiol"},{"key":"ref161","first-page":"45","article-title":"Chemotherapy for intraperitoneal use: a review of hyperthermic intraperitoneal chemotherapy and early post-operative intraperitoneal chemotherapy","volume":"7","year":"2016","journal-title":"J Gastrointest Oncol"},{"key":"ref871","first-page":"216","article-title":"Tumor-penetrating peptides","volume":"3","year":"2013;","journal-title":"Front Oncol"},{"key":"ref291","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4103\/0972-9941.158965","article-title":"Laparoscopic HIPEC: a bridge between open and closed-techniques","volume":"12","year":"2016","journal-title":"J Minim Access Surg"},{"key":"ref1851","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1208\/s12248-015-9785-x","article-title":"Versatility of particulate carriers: development of pharmacodynamically optimized drug-loaded microparticles for treatment of peritoneal cancer","volume":"17","year":"2015","journal-title":"AAPS J"},{"key":"ref791","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1124\/jpet.107.121632","article-title":"Tumor priming enhances delivery and efficacy of nanomedicines","volume":"322","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"ref1031","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1097\/01.sla.0000143245.28656.15","article-title":"Patterns of initial recurrence in completely resected gastric adenocarcinoma","volume":"240","year":"2004","journal-title":"Ann Surg"},{"key":"ref251","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/BF00348209","article-title":"Continuous hyperthermic peritoneal perfusion for the prevention of peritoneal recurrence of gastric cancer: randomized controlled study","volume":"18","year":"1994","journal-title":"World J Surg"},{"key":"ref2031","article-title":"Niraparib maintenance therapy in platinum-sensitive, recurrent ovarian cancer","year":"2016","journal-title":"N Engl J Med"},{"key":"ref301","first-page":"253","article-title":"Hyperthermic peritoneal perfusion system in canines","volume":"40","year":"1980","journal-title":"Cancer Res"},{"key":"ref1351","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/CCO.0b013e3283025e50","article-title":"Regional hyperthermia in high-risk soft tissue sarcomas","volume":"20","year":"2008","journal-title":"Curr Opin Oncol"},{"key":"ref521","first-page":"6371","article-title":"Interstitial hypertension in human breast and colorectal tumors","volume":"52","year":"1992","journal-title":"Cancer Res"},{"key":"ref421","first-page":"F413","article-title":"A distributed model of peritoneal-plasma transport: analysis of experimental data in the rat","volume":"248","year":"1985","journal-title":"Am J Physiol"},{"key":"ref1871","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/j.nano.2016.04.013","article-title":"Improving paclitaxel pharmacokinetics by using tumor-specific mesoporous silica nanoparticles with intraperitoneal delivery","volume":"12","year":"2016","journal-title":"Nanomedicine"},{"key":"ref1641","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.mehy.2015.07.001","article-title":"Pressurized intraperitoneal aerosol chemotherapy as an innovative approach to treat peritoneal carcinomatosis","volume":"85","year":"2015","journal-title":"Med Hypotheses"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ctrv.2016.06.007","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of gastrointestinal cancers with peritoneal metastases: progress toward a new standard of care","volume":"48","year":"2016","journal-title":"Cancer Treat Rev"},{"key":"ref961","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ygyno.2012.09.020","article-title":"Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: a case-control study on survival in patients with two year follow-up","volume":"127","year":"2012","journal-title":"Gynecol Oncol"},{"key":"ref561","doi-asserted-by":"crossref","first-page":"29889","DOI":"10.18632\/oncotarget.5092","article-title":"Pretreatment with VEGF(R)-inhibitors reduces interstitial fluid pressure, increases intraperitoneal chemotherapy drug penetration, and impedes tumor growth in a mouse colorectal carcinomatosis model","volume":"6","year":"2015","journal-title":"Oncotarget"},{"key":"ref1131","first-page":"F425","article-title":"A distributed model of peritoneal-plasma transport: tissue concentration gradients","volume":"248","year":"1985","journal-title":"Am J Physiol"},{"key":"ref1061","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/0360-3016(83)90384-X","article-title":"Patterns of recurrence in adenocarcinoma of the rectum and rectosigmoid treated with surgery alone: implications in treatment planning with adjuvant radiation therapy","volume":"9","year":"1983","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref1481","doi-asserted-by":"crossref","first-page":"F433","DOI":"10.1152\/ajprenal.00313.2004","article-title":"The transport barrier in intraperitoneal therapy","volume":"288","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref371","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0959-8049(01)00058-2","article-title":"Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin","volume":"37","year":"2001","journal-title":"Eur J Cancer"},{"key":"ref1151","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/jps.2600710704","article-title":"Concentration-dependent disappearance of fluorouracil from peritoneal fluid in the rat: experimental observations and distributed modeling","volume":"71","year":"1982","journal-title":"J Pharm Sci"},{"key":"ref1761","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/jps.2600740902","article-title":"Lymphatic transport of liposome-encapsulated agents: effects of liposome size following intraperitoneal administration","volume":"74","year":"1985","journal-title":"J Pharm Sci"},{"key":"ref1281","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0748-7983(97)90750-2","article-title":"Peritoneal carcinomatosis treatment with curative intent: the Institut Gustave-Roussy experience","volume":"23","year":"1997","journal-title":"Eur J Surg Oncol"},{"key":"ref821","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jconrel.2013.09.011","article-title":"Paclitaxel-loaded polymeric microparticles: quantitative relationships between in vitro drug release rate and in vivo pharmacodynamics","volume":"172","year":"2013","journal-title":"J Control Release"},{"key":"ref321","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1040-8428(01)00179-2","article-title":"The cellular and molecular basis of hyperthermia","volume":"43","year":"2002","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref811","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s11095-007-9298-0","article-title":"Effects of carrier on disposition and antitumor activity of intraperitoneal paclitaxel","volume":"24","year":"2007","journal-title":"Pharm Res"},{"key":"ref1251","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s004230050246","article-title":"Management of peritoneal-surface malignancy: the surgeon\u2019s role","volume":"384","year":"1999","journal-title":"Langenbecks Arch Surg"},{"key":"ref2021","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-0-387-68969-2_14","article-title":"Syngeneic mouse model of epithelial ovarian cancer: effects of nanoparticulate paclitaxel, Nanotax","volume":"622","year":"2008;","journal-title":"Adv Exp Med Biol"},{"key":"ref1211","first-page":"1191","article-title":"A modeling analysis of monoclonal antibody percolation through tumors: a binding-site barrier","volume":"31","year":"1990","journal-title":"J Nucl Med"},{"key":"ref221","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/978-1-4613-1247-5_18","article-title":"Methodologic considerations in treatment using intraperitoneal chemotherapy","volume":"82","year":"1996;","journal-title":"Cancer Treat Res"},{"key":"ref1201","first-page":"5475","article-title":"Measurement of local Mr 97,000 and 250,000 protein antigen concentration in sections of human melanoma tumor using in vitro quantitative autoradiography","volume":"48","year":"1988","journal-title":"Cancer Res"},{"key":"ref111","first-page":"F425","article-title":"A distributed model of peritoneal-plasma transport: tissue concentration gradients","volume":"248","year":"1985","journal-title":"Am J Physiol"},{"key":"ref1811","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1124\/jpet.107.121632","article-title":"Tumor priming enhances delivery and efficacy of nanomedicines","volume":"322","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"ref1951","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1158\/1535-7163.MCT-15-0713-T","article-title":"Paclitaxel-loaded polymersomes for enhanced intraperitoneal chemotherapy","volume":"15","year":"2016","journal-title":"Mol Cancer Ther"},{"key":"ref241","first-page":"530","article-title":"Hyperthermo-chemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination","year":"1991","journal-title":"World J Surg"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1097\/01.sla.0000143245.28656.15","article-title":"Patterns of initial recurrence in completely resected gastric adenocarcinoma","volume":"240","year":"2004","journal-title":"Ann Surg"},{"key":"ref1271","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/BF00348209","article-title":"Continuous hyperthermic peritoneal perfusion for the prevention of peritoneal recurrence of gastric cancer: randomized controlled study","volume":"18","year":"1994","journal-title":"World J Surg"},{"key":"ref1721","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1245\/s10434-015-4954-9","article-title":"Exploring the spatial drug distribution pattern of pressurized intraperitoneal aerosol chemotherapy (PIPAC","volume":"23","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"ref1571","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1124\/jpet.108.140095","article-title":"Tumor-penetrating microparticles for intraperitoneal therapy of ovarian cancer","volume":"327","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/jps.2600710704","article-title":"Concentration-dependent disappearance of fluorouracil from peritoneal fluid in the rat: experimental observations and distributed modeling","volume":"71","year":"1982","journal-title":"J Pharm Sci"},{"key":"ref1221","first-page":"5656","article-title":"Modeling analysis of the global and microscopic distribution of immunoglobulin G, F(ab\u2019)2, and Fab in tumors","volume":"49","year":"1989","journal-title":"Cancer Res"},{"key":"ref1451","first-page":"F15","article-title":"Bidirectional peritoneal transport of immunoglobulin in rats: tissue concentration profiles","volume":"263","year":"1992","journal-title":"Am J Physiol"},{"key":"ref541","first-page":"6695","article-title":"Interstitial hypertension in carcinoma of uterine cervix in patients: possible correlation with tumor oxygenation and radiation response","volume":"51","year":"1991","journal-title":"Cancer Res"},{"key":"ref1261","first-page":"530","article-title":"Hyperthermo-chemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination","year":"1991","journal-title":"World J Surg"},{"key":"ref591","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00464-011-1964-y","article-title":"Therapeutic approach of human peritoneal carcinomatosis with Dbait in combination with capnoperitoneum: proof of concept","volume":"26","year":"2012","journal-title":"Surg Endosc"},{"key":"ref1491","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1158\/1078-0432.CCR-04-2332","article-title":"Resistance of tumor interstitial pressure to the penetration of intraperitoneally delivered antibodies into metastatic ovarian tumors","volume":"11","year":"2005","journal-title":"Clin Cancer Res"},{"key":"ref971","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1245\/s10434-015-5050-x","article-title":"Long-term survival for platinum-sensitive recurrent ovarian cancer patients treated with secondary cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC","volume":"23","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"ref1231","doi-asserted-by":"crossref","first-page":"751","DOI":"10.4049\/jimmunol.132.2.751","article-title":"The interaction of monoclonal antibodies with MHC class I antigens on mouse spleen cells. I. Analysis of the mechanism of binding","volume":"132","year":"1984","journal-title":"J Immunol"},{"key":"ref1561","first-page":"6695","article-title":"Interstitial hypertension in carcinoma of uterine cervix in patients: possible correlation with tumor oxygenation and radiation response","volume":"51","year":"1991","journal-title":"Cancer Res"},{"key":"ref1331","first-page":"256","article-title":"Clinical delivery system for intraperitoneal hyperthermic chemotherapy","volume":"40","year":"1980","journal-title":"Cancer Res"},{"key":"ref1051","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/jso.21959","article-title":"Peritoneal carcinomatosis of colon cancer origin: highest incidence in women and in patients with right-sided tumors","volume":"104","year":"2011","journal-title":"J Surg Oncol"},{"key":"ref691","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.21873\/anticanres.11008","article-title":"Evaluating the effect of micropump(c) position, internal pressure and doxorubicin dosage on efficacy of Pressurized Intra-peritoneal Aerosol Chemotherapy (PIPAC) in an ex vivo model","volume":"36","year":"2016","journal-title":"Anticancer Res"},{"key":"ref1691","article-title":"In vivo feasibility of electrostatic precipitation as an adjunct to pressurized intraperitoneal aerosol chemotherapy (ePIPAC","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"ref191","first-page":"1191","article-title":"A modeling analysis of monoclonal antibody percolation through tumors: a binding-site barrier","volume":"31","year":"1990","journal-title":"J Nucl Med"},{"key":"ref1551","first-page":"5110","article-title":"Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse","volume":"52","year":"1992","journal-title":"Cancer Res"},{"key":"ref1411","first-page":"152","article-title":"Hyperthermic intraperitoneal chemoperfusion in the treatment of locally advanced intra-abdominal cancer","volume":"88","year":"2001","journal-title":"Br J Surg"},{"key":"ref1711","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.21873\/anticanres.11008","article-title":"Evaluating the effect of micropump(c) position, internal pressure and doxorubicin dosage on efficacy of Pressurized Intra-peritoneal Aerosol Chemotherapy (PIPAC) in an ex vivo model","volume":"36","year":"2016","journal-title":"Anticancer Res"},{"key":"ref911","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1126\/science.1183057","article-title":"Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs","volume":"328","year":"2010","journal-title":"Science"},{"key":"ref1981","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ygyno.2012.09.020","article-title":"Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: a case-control study on survival in patients with two year follow-up","volume":"127","year":"2012","journal-title":"Gynecol Oncol"},{"key":"ref451","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0168-3659(97)00238-1","article-title":"Tissue-level transport mechanisms of intraperitoneally-administered monoclonal antibodies","volume":"53","year":"1998","journal-title":"J Control Release"},{"key":"ref1511","first-page":"131","article-title":"Intraperitoneal drug therapy: physical and and biological principles","volume":"134","year":"2007;","journal-title":"Cancer Treat Res"},{"key":"ref841","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2967\/jnumed.112.106609","article-title":"Neutron-activatable holmium-containing mesoporous silica nanoparticles as a potential radionuclide therapeutic agent for ovarian cancer","volume":"54","year":"2013","journal-title":"J Nucl Med"},{"key":"ref1771","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ygyno.2006.02.029","article-title":"A phase I trial of intraperitoneal sustained-release paclitaxel microspheres (Paclimer) in recurrent ovarian cancer: a Gynecologic Oncology Group study","volume":"103","year":"2006","journal-title":"Gynecol Oncol"},{"key":"ref1921","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1158\/1535-7163.MCT-14-0366","article-title":"Tumor-penetrating iRGD peptide inhibits metastasis","volume":"14","year":"2015","journal-title":"Mol Cancer Ther"},{"key":"ref1931","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1126\/science.1183057","article-title":"Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs","volume":"328","year":"2010","journal-title":"Science"},{"key":"ref1521","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/scientificamerican0794-58","article-title":"Barriers to drug delivery in solid tumors","volume":"271","year":"1994","journal-title":"Sci Am"},{"key":"ref771","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0022-3565(24)34976-6","article-title":"Determinants of paclitaxel penetration and accumulation in human solid tumor","volume":"290","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"ref1021","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.critrevonc.2015.03.007","article-title":"Hyperthermic intraperitoneal chemotherapy for the treatment of ovarian cancer: a brief overview of recent results","volume":"95","year":"2015","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref1421","doi-asserted-by":"crossref","first-page":"F875","DOI":"10.1152\/ajprenal.2000.278.6.F875","article-title":"Effect of intraperitoneal pressures on tissue water of the abdominal muscle","volume":"278","year":"2000","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref1471","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0168-3659(97)00238-1","article-title":"Tissue-level transport mechanisms of intraperitoneally-administered monoclonal antibodies","volume":"53","year":"1998","journal-title":"J Control Release"},{"key":"ref1801","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0022-3565(24)38848-2","article-title":"Enhancement of paclitaxel delivery to solid tumors by apoptosis-inducing pretreatment: effect of treatment schedule","volume":"296","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"ref1831","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s11095-007-9298-0","article-title":"Effects of carrier on disposition and antitumor activity of intraperitoneal paclitaxel","volume":"24","year":"2007","journal-title":"Pharm Res"},{"key":"ref661","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1007\/s00464-015-4738-0","article-title":"Feasibility of hyperthermic pressurized intraperitoneal aerosol chemotherapy in a porcine model","volume":"30","year":"2016","journal-title":"Surg Endosc"},{"key":"ref411","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1681\/ASN.V72225","article-title":"Small-solute transport across specific peritoneal tissue surfaces in the rat","volume":"7","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"ref1971","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ygyno.2011.04.008","article-title":"HIPEC in recurrent ovarian cancer patients: morbidity-related treatment and long-term analysis of clinical outcome","volume":"122","year":"2011","journal-title":"Gynecol Oncol"},{"key":"ref531","first-page":"5110","article-title":"Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse","volume":"52","year":"1992","journal-title":"Cancer Res"},{"key":"ref801","first-page":"256","article-title":"Nanoscopic tumor tissue distribution of platinum after intraperitoneal administration in a xenograft model of ovarian cancer","volume":"30","year":"2016","journal-title":"J Pharm Biomed Anal"},{"key":"ref1041","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/SLA.0b013e31827fe9ce","article-title":"Failure patterns in resected pancreas adenocarcinoma: lack of predicted benefit to SMAD4 expression","volume":"258","year":"2013","journal-title":"Ann Surg"},{"key":"ref1741","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s00432-016-2234-0","article-title":"Distribution pattern and penetration depth of doxorubicin after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in a postmortem swine model","volume":"142","year":"2016","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref501","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/scientificamerican0794-58","article-title":"Barriers to drug delivery in solid tumors","volume":"271","year":"1994","journal-title":"Sci Am"},{"key":"ref1241","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/978-1-4613-1247-5_18","article-title":"Methodologic considerations in treatment using intraperitoneal chemotherapy","volume":"82","year":"1996;","journal-title":"Cancer Treat Res"},{"key":"ref1991","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1245\/s10434-015-5050-x","article-title":"Long-term survival for platinum-sensitive recurrent ovarian cancer patients treated with secondary cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC","volume":"23","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"ref441","first-page":"F275","article-title":"Bidirectional peritoneal transport of immunoglobulin in rats: compartmental kinetics","volume":"262","year":"1992","journal-title":"Am J Physiol"},{"key":"ref571","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s004649900010","article-title":"Feasibility of therapeutic pneumoperitoneum in a large animal model using a microvaporisator","volume":"14","year":"2000","journal-title":"Surg Endosc"},{"key":"ref1911","first-page":"59","article-title":"A tumor-penetrating peptide enhances circulation-independent targeting of peritoneal carcinomatosis","volume":"28","year":"2015","journal-title":"J Control Release"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s00432-009-0667-4","article-title":"Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results","volume":"135","year":"2009","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref551","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1124\/jpet.108.140095","article-title":"Tumor-penetrating microparticles for intraperitoneal therapy of ovarian cancer","volume":"327","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"ref781","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0022-3565(24)38848-2","article-title":"Enhancement of paclitaxel delivery to solid tumors by apoptosis-inducing pretreatment: effect of treatment schedule","volume":"296","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"ref311","first-page":"256","article-title":"Clinical delivery system for intraperitoneal hyperthermic chemotherapy","volume":"40","year":"1980","journal-title":"Cancer Res"},{"key":"ref281","first-page":"232","article-title":"Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C","volume":"1561","year":"1988","journal-title":"Cancer"},{"key":"ref891","first-page":"59","article-title":"A tumor-penetrating peptide enhances circulation-independent targeting of peritoneal carcinomatosis","volume":"28","year":"2015","journal-title":"J Control Release"},{"key":"ref921","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.biomaterials.2016.07.023","article-title":"iRGD peptide conjugation potentiates intraperitoneal tumor delivery of paclitaxel with polymersomes","volume":"104","year":"2016","journal-title":"Biomaterials"},{"key":"ref981","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejca.2016.01.017","article-title":"Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): final analysis of peri-operative outcome","volume":"59","year":"2016","journal-title":"Eur J Cancer"},{"key":"ref1291","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00000658-198807000-00005","article-title":"Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding","volume":"208","year":"1988","journal-title":"Ann Surg"},{"key":"ref1901","doi-asserted-by":"crossref","first-page":"16157","DOI":"10.1073\/pnas.0908201106","article-title":"C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration","volume":"106","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref831","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1208\/s12248-015-9785-x","article-title":"Versatility of particulate carriers: development of pharmacodynamically optimized drug-loaded microparticles for treatment of peritoneal cancer","volume":"17","year":"2015","journal-title":"AAPS J"},{"key":"ref381","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1046\/j.1365-2168.2001.01701.x","article-title":"Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei","volume":"88","year":"2001","journal-title":"Br J Surg"},{"key":"ref271","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00000658-198807000-00005","article-title":"Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding","volume":"208","year":"1988","journal-title":"Ann Surg"},{"key":"ref1341","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1040-8428(01)00179-2","article-title":"The cellular and molecular basis of hyperthermia","volume":"43","year":"2002","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref1781","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0169-409X(97)00048-3","article-title":"Biodegradation and biocompatibility of PLA and PLGA microspheres","volume":"28","year":"1997","journal-title":"Adv Drug Deliv Rev"},{"key":"ref1621","first-page":"6723","article-title":"Pressurized intraperitoneal aerosol chemotherapy with cisplatin and doxorubicin in women with peritoneal carcinomatosis: a cohort study","volume":"35","year":"2015","journal-title":"Anticancer Res"},{"key":"ref351","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1053\/ejso.2000.0964","article-title":"Peroperative hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced gastric cancer","volume":"26","year":"2000","journal-title":"Eur J Surg Oncol"},{"key":"ref1371","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1053\/ejso.2000.0964","article-title":"Peroperative hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced gastric cancer","volume":"26","year":"2000","journal-title":"Eur J Surg Oncol"},{"key":"ref1181","first-page":"45","article-title":"Chemotherapy for intraperitoneal use: a review of hyperthermic intraperitoneal chemotherapy and early post-operative intraperitoneal chemotherapy","volume":"7","year":"2016","journal-title":"J Gastrointest Oncol"},{"key":"ref261","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0748-7983(97)90750-2","article-title":"Peritoneal carcinomatosis treatment with curative intent: the Institut Gustave-Roussy experience","volume":"23","year":"1997","journal-title":"Eur J Surg Oncol"},{"key":"ref461","doi-asserted-by":"crossref","first-page":"F433","DOI":"10.1152\/ajprenal.00313.2004","article-title":"The transport barrier in intraperitoneal therapy","volume":"288","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref651","article-title":"Additive treatment improves survival in elderly patients after non-curative endoscopic resection for early gastric cancer","year":"2016","journal-title":"Surg Endosc"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"751","DOI":"10.4049\/jimmunol.132.2.751","article-title":"The interaction of monoclonal antibodies with MHC class I antigens on mouse spleen cells. I. Analysis of the mechanism of binding","volume":"132","year":"1984","journal-title":"J Immunol"},{"key":"ref1961","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ygyno.2009.03.004","article-title":"Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum-sensitive recurrent ovarian cancer patients: a pilot study","volume":"113","year":"2009","journal-title":"Gynecol Oncol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/SLA.0b013e31827fe9ce","article-title":"Failure patterns in resected pancreas adenocarcinoma: lack of predicted benefit to SMAD4 expression","volume":"258","year":"2013","journal-title":"Ann Surg"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12957-016-1008-0","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"14","year":"2016","journal-title":"World J Surg Oncol"},{"key":"ref1731","doi-asserted-by":"crossref","first-page":"910","DOI":"10.7150\/jca.14714","article-title":"Effect of irradiation on tissue penetration depth of doxorubicin after Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) in a novel ex-vivo model","volume":"7","year":"2016;","journal-title":"J Cancer"},{"key":"ref1121","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1681\/ASN.V22122","article-title":"Peritoneal transport physiology: insights from basic research","volume":"2","year":"1991","journal-title":"J Am Soc Nephrol"},{"key":"ref1011","article-title":"Niraparib maintenance therapy in platinum-sensitive, recurrent ovarian cancer","year":"2016","journal-title":"N Engl J Med"},{"key":"ref1821","first-page":"256","article-title":"Nanoscopic tumor tissue distribution of platinum after intraperitoneal administration in a xenograft model of ovarian cancer","volume":"30","year":"2016","journal-title":"J Pharm Biomed Anal"},{"key":"ref1111","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1177\/089686089701700610","article-title":"Computerized kinetic modeling: a new tool in the quest for adequacy in peritoneal dialysis","volume":"17","year":"1997","journal-title":"Perit Dial Int"},{"key":"ref431","first-page":"F15","article-title":"Bidirectional peritoneal transport of immunoglobulin in rats: tissue concentration profiles","volume":"263","year":"1992","journal-title":"Am J Physiol"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.2217\/fon.10.100","article-title":"Intraperitoneal therapy for peritoneal cancer","volume":"6","year":"2010","journal-title":"Future Oncol"},{"key":"ref621","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.mehy.2015.07.001","article-title":"Pressurized intraperitoneal aerosol chemotherapy as an innovative approach to treat peritoneal carcinomatosis","volume":"85","year":"2015","journal-title":"Med Hypotheses"},{"key":"ref851","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/j.nano.2016.04.013","article-title":"Improving paclitaxel pharmacokinetics by using tumor-specific mesoporous silica nanoparticles with intraperitoneal delivery","volume":"12","year":"2016","journal-title":"Nanomedicine"},{"key":"ref1361","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/bjc.1995.334","article-title":"Hyperthermia, thermotolerance and topoisomerase II inhibitors","volume":"72","year":"1995","journal-title":"Br J Cancer"},{"key":"ref331","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/CCO.0b013e3283025e50","article-title":"Regional hyperthermia in high-risk soft tissue sarcomas","volume":"20","year":"2008","journal-title":"Curr Opin Oncol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/0360-3016(83)90384-X","article-title":"Patterns of recurrence in adenocarcinoma of the rectum and rectosigmoid treated with surgery alone: implications in treatment planning with adjuvant radiation therapy","volume":"9","year":"1983","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref01","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.critrevonc.2015.03.007","article-title":"Hyperthermic intraperitoneal chemotherapy for the treatment of ovarian cancer: a brief overview of recent results","volume":"95","year":"2015","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/BF00686048","article-title":"Platinum distribution in intraperitoneal tumors after intraperitoneal cisplatin treatment","volume":"25","year":"1990","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref1501","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1158\/1078-0432.CCR-05-2141","article-title":"Intraperitoneal immunotherapy for metastatic ovarian carcinoma: resistance of intratumoral collagen to antibody penetration","volume":"12","year":"2006","journal-title":"Clin Cancer Res"},{"key":"ref1651","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1245\/s10434-012-2840-2","article-title":"Renal and hepatic toxicities after pressurized intraperitoneal aerosol chemotherapy (PIPAC","volume":"20","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"ref1791","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0022-3565(24)34976-6","article-title":"Determinants of paclitaxel penetration and accumulation in human solid tumor","volume":"290","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"ref1671","article-title":"Additive treatment improves survival in elderly patients after non-curative endoscopic resection for early gastric cancer","year":"2016","journal-title":"Surg Endosc"},{"key":"ref1881","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1021\/acs.bioconjchem.5b00674","article-title":"Production of cisplatin-incorporating hyaluronan nanogels via chelating ligand-metal coordination","volume":"27","year":"2016","journal-title":"Bioconjug Chem"},{"key":"ref1431","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1681\/ASN.V72225","article-title":"Small-solute transport across specific peritoneal tissue surfaces in the rat","volume":"7","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"ref1701","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1245\/s10434-013-3213-1","article-title":"Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressurized aerosol as an alternative to liquid solution: first evidence for efficacy","volume":"21","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"ref471","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1158\/1078-0432.CCR-04-2332","article-title":"Resistance of tumor interstitial pressure to the penetration of intraperitoneally delivered antibodies into metastatic ovarian tumors","volume":"11","year":"2005","journal-title":"Clin Cancer Res"},{"key":"ref901","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1158\/1535-7163.MCT-14-0366","article-title":"Tumor-penetrating iRGD peptide inhibits metastasis","volume":"14","year":"2015","journal-title":"Mol Cancer Ther"},{"key":"ref1381","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1053\/ctrv.2001.0232","article-title":"Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy","volume":"27","year":"2001","journal-title":"Cancer Treat Rev"},{"key":"ref1071","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ctrv.2016.06.007","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of gastrointestinal cancers with peritoneal metastases: progress toward a new standard of care","volume":"48","year":"2016","journal-title":"Cancer Treat Rev"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1681\/ASN.V22122","article-title":"Peritoneal transport physiology: insights from basic research","volume":"2","year":"1991","journal-title":"J Am Soc Nephrol"},{"key":"ref861","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1021\/acs.bioconjchem.5b00674","article-title":"Production of cisplatin-incorporating hyaluronan nanogels via chelating ligand-metal coordination","volume":"27","year":"2016","journal-title":"Bioconjug Chem"},{"key":"ref1091","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12957-016-1008-0","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"14","year":"2016","journal-title":"World J Surg Oncol"},{"key":"ref611","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ygyno.2015.02.009","article-title":"Pressurized intraperitoneal aerosol chemotherapy in women with recurrent ovarian cancer: a phase 2 study","volume":"137","year":"2015","journal-title":"Gynecol Oncol"},{"key":"ref1191","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1208\/s12248-014-9574-y","article-title":"Multiscale tumor spatiokinetic model for intraperitoneal therapy","volume":"16","year":"2014","journal-title":"AAPS J"},{"key":"ref711","doi-asserted-by":"crossref","first-page":"910","DOI":"10.7150\/jca.14714","article-title":"Effect of irradiation on tissue penetration depth of doxorubicin after Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) in a novel ex-vivo model","volume":"7","year":"2016;","journal-title":"J Cancer"},{"key":"ref1161","first-page":"3380","article-title":"Direct diffusion of cis-diamminedichloroplatinum(II) in intraperitoneal rat tumors after intraperitoneal chemotherapy: a comparison with systemic chemotherapy","volume":"49","year":"1989","journal-title":"Cancer Res"},{"key":"ref1581","doi-asserted-by":"crossref","first-page":"29889","DOI":"10.18632\/oncotarget.5092","article-title":"Pretreatment with VEGF(R)-inhibitors reduces interstitial fluid pressure, increases intraperitoneal chemotherapy drug penetration, and impedes tumor growth in a mouse colorectal carcinomatosis model","volume":"6","year":"2015","journal-title":"Oncotarget"},{"key":"ref491","first-page":"131","article-title":"Intraperitoneal drug therapy: physical and and biological principles","volume":"134","year":"2007;","journal-title":"Cancer Treat Res"},{"key":"ref631","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1245\/s10434-012-2840-2","article-title":"Renal and hepatic toxicities after pressurized intraperitoneal aerosol chemotherapy (PIPAC","volume":"20","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"ref641","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.ejso.2015.06.001","article-title":"Quality of life of patients with end-stage peritoneal metastasis treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC","volume":"41","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"ref1751","first-page":"H26","article-title":"Peritoneal absorption of macromolecules studied by quantitative autoradiography","volume":"248","year":"1985","journal-title":"Am J Physiol"},{"key":"ref1661","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.ejso.2015.06.001","article-title":"Quality of life of patients with end-stage peritoneal metastasis treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC","volume":"41","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"ref1301","first-page":"232","article-title":"Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C","volume":"1561","year":"1988","journal-title":"Cancer"},{"key":"ref741","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/jps.2600740902","article-title":"Lymphatic transport of liposome-encapsulated agents: effects of liposome size following intraperitoneal administration","volume":"74","year":"1985","journal-title":"J Pharm Sci"},{"key":"ref141","first-page":"3380","article-title":"Direct diffusion of cis-diamminedichloroplatinum(II) in intraperitoneal rat tumors after intraperitoneal chemotherapy: a comparison with systemic chemotherapy","volume":"49","year":"1989","journal-title":"Cancer Res"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1208\/s12248-014-9574-y","article-title":"Multiscale tumor spatiokinetic model for intraperitoneal therapy","volume":"16","year":"2014","journal-title":"AAPS J"},{"key":"ref401","doi-asserted-by":"crossref","first-page":"F875","DOI":"10.1152\/ajprenal.2000.278.6.F875","article-title":"Effect of intraperitoneal pressures on tissue water of the abdominal muscle","volume":"278","year":"2000","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref941","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ygyno.2009.03.004","article-title":"Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum-sensitive recurrent ovarian cancer patients: a pilot study","volume":"113","year":"2009","journal-title":"Gynecol Oncol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/jso.21959","article-title":"Peritoneal carcinomatosis of colon cancer origin: highest incidence in women and in patients with right-sided tumors","volume":"104","year":"2011","journal-title":"J Surg Oncol"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s004230050246","article-title":"Management of peritoneal-surface malignancy: the surgeon\u2019s role","volume":"384","year":"1999","journal-title":"Langenbecks Arch Surg"},{"key":"ref1141","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.2217\/fon.10.100","article-title":"Intraperitoneal therapy for peritoneal cancer","volume":"6","year":"2010","journal-title":"Future Oncol"},{"key":"ref1391","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0959-8049(01)00058-2","article-title":"Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin","volume":"37","year":"2001","journal-title":"Eur J Cancer"},{"key":"ref1171","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/BF00686048","article-title":"Platinum distribution in intraperitoneal tumors after intraperitoneal cisplatin treatment","volume":"25","year":"1990","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref1531","first-page":"4478","article-title":"Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy","volume":"150","year":"1990","journal-title":"Cancer Res"},{"key":"ref201","first-page":"5656","article-title":"Modeling analysis of the global and microscopic distribution of immunoglobulin G, F(ab\u2019)2, and Fab in tumors","volume":"49","year":"1989","journal-title":"Cancer Res"},{"key":"ref751","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ygyno.2006.02.029","article-title":"A phase I trial of intraperitoneal sustained-release paclitaxel microspheres (Paclimer) in recurrent ovarian cancer: a Gynecologic Oncology Group study","volume":"103","year":"2006","journal-title":"Gynecol Oncol"},{"key":"ref931","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1158\/1535-7163.MCT-15-0713-T","article-title":"Paclitaxel-loaded polymersomes for enhanced intraperitoneal chemotherapy","volume":"15","year":"2016","journal-title":"Mol Cancer Ther"},{"key":"ref2001","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejca.2016.01.017","article-title":"Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): final analysis of peri-operative outcome","volume":"59","year":"2016","journal-title":"Eur J Cancer"},{"key":"ref1101","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/jnci\/89.7.480","article-title":"Pharmacokinetic problems in peritoneal drug administration: tissue penetration and surface exposure","volume":"89","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"ref1841","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jconrel.2013.09.011","article-title":"Paclitaxel-loaded polymeric microparticles: quantitative relationships between in vitro drug release rate and in vivo pharmacodynamics","volume":"172","year":"2013","journal-title":"J Control Release"},{"key":"ref2011","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00280-015-2737-4","article-title":"A phase I study of intraperitoneal nanoparticulate paclitaxel (Nanotax(R)) in patients with peritoneal malignancies","volume":"75","year":"2015","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref581","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s00464-012-2148-0","article-title":"Description of a novel approach for intraperitoneal drug delivery and the related device","volume":"26","year":"2012","journal-title":"Surg Endosc"},{"key":"ref1461","first-page":"F275","article-title":"Bidirectional peritoneal transport of immunoglobulin in rats: compartmental kinetics","volume":"262","year":"1992","journal-title":"Am J Physiol"},{"key":"ref1861","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2967\/jnumed.112.106609","article-title":"Neutron-activatable holmium-containing mesoporous silica nanoparticles as a potential radionuclide therapeutic agent for ovarian cancer","volume":"54","year":"2013","journal-title":"J Nucl Med"},{"key":"ref391","first-page":"152","article-title":"Hyperthermic intraperitoneal chemoperfusion in the treatment of locally advanced intra-abdominal cancer","volume":"88","year":"2001","journal-title":"Br J Surg"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1177\/089686089701700610","article-title":"Computerized kinetic modeling: a new tool in the quest for adequacy in peritoneal dialysis","volume":"17","year":"1997","journal-title":"Perit Dial Int"},{"key":"ref1631","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ygyno.2015.02.009","article-title":"Pressurized intraperitoneal aerosol chemotherapy in women with recurrent ovarian cancer: a phase 2 study","volume":"137","year":"2015","journal-title":"Gynecol Oncol"},{"key":"ref671","article-title":"In vivo feasibility of electrostatic precipitation as an adjunct to pressurized intraperitoneal aerosol chemotherapy (ePIPAC","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"ref721","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s00432-016-2234-0","article-title":"Distribution pattern and penetration depth of doxorubicin after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in a postmortem swine model","volume":"142","year":"2016","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["Pleura and Peritoneum"],"original-title":[],"link":[{"URL":"https:\/\/www.degruyter.com\/view\/journals\/pp\/1\/4\/article-p183.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/pp-2016-0022\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T18:26:34Z","timestamp":1749839194000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/pp-2016-0022\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,1]]},"references-count":204,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.1515\/pp-2016-0022","relation":{},"ISSN":["2364-7671","2364-768X"],"issn-type":[{"value":"2364-7671","type":"print"},{"value":"2364-768X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,1]]}}}